NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25376646.
- Also identified by DOI 10.1038/ncomms6176.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Runt-related transcription factor 2 (Runx2) transactivates many genes required for osteoblast differentiation. The role of N-α-acetyltransferase 10 (NAA10, arrest-defective-1), originally identified in yeast, remains poorly understood in mammals. Here we report a new NAA10 function in Runx2-mediated osteogenesis. Runx2 stabilizes NAA10 in osteoblasts during BMP-2-induced differentiation, and NAA10 in turn controls this differentiation by inhibiting Runx2. NAA10 delays bone healing in a rat calvarial defect model and bone development in neonatal mice. Mechanistically, NAA10 acetylates Runx2 at Lys225, and this acetylation inhibits Runx2-driven transcription by interfering with CBFβ binding to Runx2. Our study suggests that NAA10 acts as a guard ensuring balanced osteogenesis by fine-tuning Runx2 signalling in a feedback manner. NAA10 inhibition could be considered a potential strategy for facilitating bone formation.
Medical subject headings
- Cell Differentiation
- Core Binding Factor Alpha 1 Subunit
- Feedback, Physiological
- N-Terminal Acetyltransferase A
- N-Terminal Acetyltransferase E
- Osteoblasts
- Osteogenesis